Comparative efficacy in smokers with versus without COPD: a new addition of an old drug to approved pharmacotherapy for smoking cessation
Related Posts
Cho JL, Camac E, Bernardo RJ, Carmona H, Del Valle KT, Forbes LM, Kolaitis NA, Mathai SK, Maximous SI, Melamed KH, Peck TJ, Soffler M,[...]
Hammer AJ, Kasschau KD, Davis Ii EW, Hoffman P, Johnson-Camacho K, Alexiev A, Anderson K, Shannon J, Marriott LK, Sharpton TJ. Polycyclic aromatic hydrocarbons, gut[...]
Cromer SJ, Tesfaye H, Cho H, Wexler DJ, Ortega-Montiel J, Schmedt N, Shay CM, Paik JM, Patorno E. Effects of Empagliflozin on Cardiovascular Outcomes Are[...]